Global Pharmaceuticals & Biotech Leverage Leaders

AstraZeneca Pharma India

Market Cap: ₹212.6b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Abbott India

Market Cap: ₹543.4b

Operates as a pharmaceutical company in India.

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥19.4b

Engages in research, development, production, and sale of central nervous system products in China.

Rubicon Research

Market Cap: ₹228.7b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Krka d. d

Market Cap: €7.8b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Hisamitsu Pharmaceutical

Market Cap: US$8.2b

Manufactures and sells pharmaceuticals in Japan.

Supernus Pharmaceuticals

Market Cap: US$2.6b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Apogee Therapeutics

Market Cap: US$6.8b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States.

Neurocrine Biosciences

Market Cap: US$16.3b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥86.6b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Ipsen

Market Cap: €12.9b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

UCB

Market Cap: €47.1b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

GRAIL

Market Cap: US$2.7b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

Incyte

Market Cap: US$20.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Bio-Techne

Market Cap: US$8.7b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Enliven Therapeutics

Market Cap: US$2.8b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Agilent Technologies

Market Cap: US$35.7b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Spyre Therapeutics

Market Cap: US$8.7b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases.

PharmaEssentia

Market Cap: NT$406.9b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Santen Pharmaceutical

Market Cap: JP¥644.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Hualan Biological Engineering

Market Cap: CN¥23.7b

Engages in the research, development, production, and sale of biological products in China and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

BeBetter Med

Market Cap: CN¥14.4b

A biopharmaceutical company, engages in the research and development, and sale of drugs for tumors, autoimmune diseases, and metabolic diseases.

Shenzhen Salubris Pharmaceuticals

Market Cap: CN¥34.6b

Shenzhen Salubris Pharmaceuticals Co., Ltd.

SK Biopharmaceuticals

Market Cap: ₩6.4t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

ALTEOGEN

Market Cap: ₩17.8t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Emcure Pharmaceuticals

Market Cap: ₹344.4b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Anthem Biosciences

Market Cap: ₹435.8b

Operates as technology-focused contract research, development, and manufacturing organization.

Granules India

Market Cap: ₹195.1b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

Divi's Laboratories

Market Cap: ₹1.8t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س11.3b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

ALK-Abelló

Market Cap: DKK 56.6b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

Bavarian Nordic

Market Cap: DKK 13.7b

Develops, manufactures, and supplies life-saving vaccines.

Ligand Pharmaceuticals

Market Cap: US$5.5b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Tango Therapeutics

Market Cap: US$4.0b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.